Novel Strategies for Gene Therapy-Recent Advances in the Use of Exosomes for Disease Treatment

Author(s): Ling-Qing Yuan.

Journal Name: Current Pharmaceutical Design

Volume 25 , Issue 42 , 2019

Become EABM
Become Reviewer

[1]
Kluszczyńska K, Czernek L, Cypryk W, Pęczek L, Düchler M. Methods for the determination of the purity of exosomes. Curr Pharm Des 2019; 25(42): 4464-85.
[2]
Park EJ, Appiah MG, Myint PK, Gaowa A, Kawamoto E, Shimaoka M. Exosomes in sepsis and inflammatory tissue injury. Curr Pharm Des 2019; 25(42): 4486-95.
[3]
Li M, Jiang M, Meng J, Tao L. Exosomes: carriers of pro-fibrotic signals and therapeutic targets in fibrosis. Curr Pharm Des 2019; 25(42): 4496-509.
[4]
Longoni B, Fasciani I, Kolachalam S, et al. Neurotoxic and neuroprotective role of exosomes in Parkinson’s disease. Curr Pharm Des 2019; 25(42): 4510-22.
[5]
Tu C, He J, Chen R, Li Z. The emerging role of exosomal non-coding RNAs in musculoskeletal diseases. Curr Pharm Des 2019; 25(42): 4523-35.
[6]
Shan SK, Lin X, Li F, et al. Exosomes and bone disease. Curr Pharm Des 2019; 25(42): 4536-49.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 25
ISSUE: 42
Year: 2019
Page: [4463 - 4463]
Pages: 1
DOI: 10.2174/138161282542191230114518

Article Metrics

PDF: 22
HTML: 3